Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
International Journal of Obesity (2005)
|
July 4, 2012
Adiponectin associates positively with nitrite levels in children and adolescents
V A Belo, D C Souza-Costa, R Lacchini, et al.
Journal of Human Hypertension
|
June 20, 2014
The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents
J A de Miranda, R Lacchini, V A Belo, et al.
International Journal of Impotence Research
|
September 16, 2011
Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction
J J Muniz, R Lacchini, V A Belo, et al.
International Journal of Obesity (2005)
|
October 9, 2013
The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
V A Belo, M R Luizon, R Lacchini, et al.
The Pharmacogenomics Journal
|
November 9, 2011
Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction
J J Muniz, R Lacchini, T O Rinaldi, et al.
Journal of Human Hypertension
|
December 11, 2012
Haptoglobin polymorphism affects nitric oxide bioavailability in preeclampsia
J T Sertório, R Lacchini, L M Amaral, et al.
Journal of Human Hypertension
|
February 11, 2011
Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients
R Lacchini, A L B Jacob-Ferreira, M R Luizon, et al.
The Pharmacogenomics Journal
|
July 20, 2011
Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
A C T Palei, V C Sandrim, L M Amaral, et al.
The Pharmacogenomics Journal
|
May 12, 2016
Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
M R Luizon, A C T Palei, V A Belo, et al.
The Pharmacogenomics Journal
|
June 11, 2014
Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
M R Luizon, A C T Palei, V C Sandrim, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
International Journal of Obesity (2005)
|
July 4, 2012
Adiponectin associates positively with nitrite levels in children and adolescents
V A Belo, D C Souza-Costa, R Lacchini, et al.
Journal of Human Hypertension
|
June 20, 2014
The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents
J A de Miranda, R Lacchini, V A Belo, et al.
International Journal of Impotence Research
|
September 16, 2011
Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction
J J Muniz, R Lacchini, V A Belo, et al.
International Journal of Obesity (2005)
|
October 9, 2013
The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
V A Belo, M R Luizon, R Lacchini, et al.
The Pharmacogenomics Journal
|
November 9, 2011
Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction
J J Muniz, R Lacchini, T O Rinaldi, et al.
Journal of Human Hypertension
|
December 11, 2012
Haptoglobin polymorphism affects nitric oxide bioavailability in preeclampsia
J T Sertório, R Lacchini, L M Amaral, et al.
Journal of Human Hypertension
|
February 11, 2011
Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients
R Lacchini, A L B Jacob-Ferreira, M R Luizon, et al.
The Pharmacogenomics Journal
|
July 20, 2011
Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
A C T Palei, V C Sandrim, L M Amaral, et al.
The Pharmacogenomics Journal
|
May 12, 2016
Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
M R Luizon, A C T Palei, V A Belo, et al.
The Pharmacogenomics Journal
|
June 11, 2014
Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
M R Luizon, A C T Palei, V C Sandrim, et al.
Page
of 2